Search company, investor...

Predict your next investment

Venture Capital
fjordventures.com

Investments

23

Portfolio Exits

3

Funds

1

About Fjord Ventures

Fjord Ventures LLC was founded in mid-2005 and is committed to providing strategic vision and operational excellence to emerging life sciences companies. The Firm is based in Laguna Hills, California.

Headquarters Location

26051 Merit Circle

Laguna Hills, California, 92653-7008,

United States

Want to inform investors similar to Fjord Ventures about your company?

Submit your Analyst Briefing to get in front of investors, customers, and partners on CB Insights’ platform.

Latest Fjord Ventures News

Adagio Medical Raises $42.5M In Series E Funding

Nov 16, 2020

Adagio Medical, Inc. , a Laguna Hills, Calif.-based provider of treatments for atrial fibrillation (AF) and ventricular tachycardia (VT), and developer of the Continuous Lesion Ablation System (iCLAS™), closed a $42.5m Series E equity financing. Backers included new investors ArrowMark Partners, RA Capital Management and Perceptive Advisors, who joined existing investors including JMR Capital and Fjord Ventures. Tuan Huynh of ArrowMark and Zach Scheiner, PhD of RA Capital Management have been appointed to the Adagio Board of Directors. The company intends to use the funds to further develop the iCLAS™ Investigational Device Exemption (IDE) trial, accelerate the European VT CE-Mark trial, advance the commercialization of the iCLAS system in CE-Mark countries, and continue the development and clinical validation of its pulsed field cryoablation (PFCA) technology. Led by Olav Bergheim, President and CEO, Adagio is developing innovative cryoablation technologies that create continuous, linear, transmural lesions to treat cardiac arrhythmias, including paroxysmal and persistent atrial fibrillation, atrial flutter, and ventricular tachycardia. FinSMEs

Fjord Ventures Investments

23 Investments

Fjord Ventures has made 23 investments. Their latest investment was in Adagio Medical as part of their Series E on November 11, 2020.

CBI Logo

Fjord Ventures Investments Activity

investments chart

Date

Round

Company

Amount

New?

Co-Investors

Sources

11/13/2020

Series E

Adagio Medical

$42.5M

No

8

1/10/2020

Series E

PreludeDX

$10M

No

1

7/27/2018

Series D

PreludeDX

$9M

No

1

9/18/2017

Growth Equity

Subscribe to see more

$99M

Subscribe to see more

10

3/16/2017

Series C

Subscribe to see more

$99M

Subscribe to see more

10

Date

11/13/2020

1/10/2020

7/27/2018

9/18/2017

3/16/2017

Round

Series E

Series E

Series D

Growth Equity

Series C

Company

Adagio Medical

PreludeDX

PreludeDX

Subscribe to see more

Subscribe to see more

Amount

$42.5M

$10M

$9M

$99M

$99M

New?

No

No

No

Subscribe to see more

Subscribe to see more

Co-Investors

Sources

8

1

1

10

10

Fjord Ventures Portfolio Exits

3 Portfolio Exits

Fjord Ventures has 3 portfolio exits. Their latest portfolio exit was Sonendo on October 29, 2021.

Date

Exit

Companies

Valuation
Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model.

Acquirer

Sources

10/29/2021

IPO

$99M

Public

4

6/25/2015

IPO

Subscribe to see more

$99M

Subscribe to see more

10

9/8/2006

Acquired

Subscribe to see more

$99M

Subscribe to see more

10

Date

10/29/2021

6/25/2015

9/8/2006

Exit

IPO

IPO

Acquired

Companies

Subscribe to see more

Subscribe to see more

Valuation

$99M

$99M

$99M

Acquirer

Public

Subscribe to see more

Subscribe to see more

Sources

4

10

10

Fjord Ventures Fund History

1 Fund History

Fjord Ventures has 1 fund, including Fjord Capital Partners I LP.

Closing Date

Fund

Fund Type

Status

Amount

Sources

2/19/2010

Fjord Capital Partners I LP

Early-Stage Venture Capital

Open

$12M

1

Closing Date

2/19/2010

Fund

Fjord Capital Partners I LP

Fund Type

Early-Stage Venture Capital

Status

Open

Amount

$12M

Sources

1

Fjord Ventures Team

4 Team Members

Fjord Ventures has 4 team members, including current Chief Financial Officer, Hugh A. Neuharth.

Name

Work History

Title

Status

Hugh A. Neuharth

Chief Financial Officer

Current

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Name

Hugh A. Neuharth

Subscribe to see more

Subscribe to see more

Subscribe to see more

Work History

Title

Chief Financial Officer

Subscribe to see more

Subscribe to see more

Subscribe to see more

Status

Current

Subscribe to see more

Subscribe to see more

Subscribe to see more

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.